Literature DB >> 8185574

Molecular cloning and characterization of the promoter for human type-1 angiotensin II receptor gene.

R Takayanagi1, K Ohnaka, Y Sakai, S Ikuyama, H Nawata.   

Abstract

We isolated a genomic clone containing 2558 bp of the 5'-flanking region and 217 bp of the first exon for the human type-1 angiotensin II receptor (AT1) gene. Primer extension and RNAase protection analyses identified a transcriptional start site (+1) at 39 and 114 bp downstream of putative TATA and GC boxes, respectively. Chimeras containing 2.6 kbp(-2558 to +79) of the 5'-flanking region and chloramphenicol acetyltransferase (CAT) gene expressed a significant CAT activity when transfected into bovine aortic smooth muscle cells (BASMC), but not the cells which had no detectable AT1 receptors, such as HeLa cells and primary cultured human skin fibroblasts. Deletion of the 5'-flanking region up to position -114 resulted in more than 20-fold increase of the reporter activity in BASMC, suggesting the presence of negatively regulating element(s) in the upstream promoter region. These results indicate that we have cloned a functional promoter for the human AT1 receptor gene.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8185574     DOI: 10.1006/bbrc.1994.1587

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

Review 1.  Angiotensin II type 1 receptor polymorphisms and susceptibility to hypertension: a HuGE review.

Authors:  Amy K Mottl; David A Shoham; Kari E North
Journal:  Genet Med       Date:  2008-08       Impact factor: 8.822

2.  Renin-angiotensin system polymorphisms in Taiwanese primary vesicoureteral reflux.

Authors:  Kuo-Pao Liu; Ching-Yuang Lin; Han-Jou Chen; Chou-Fu Wei; Guey-Jen Lee-Chen
Journal:  Pediatr Nephrol       Date:  2004-03-26       Impact factor: 3.714

Review 3.  Role and therapeutic potential of G-protein coupled receptors in breast cancer progression and metastases.

Authors:  Anukriti Singh; Jessica J Nunes; Bushra Ateeq
Journal:  Eur J Pharmacol       Date:  2015-05-14       Impact factor: 4.432

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.